BioWorld

The BioWorld Insider Podcast

Science EN ↓ 53 episodes

One-on-one with medical innovators: Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma's dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collective work is changing how we all live. Join us for a new conversation.

Author

BioWorld

Episodes

Iteos brings Glaxosmithkline a third checkpoint-targeting antibody in a $2B deal 16.06.2021 12:33

Michel Detheux, president and CEO of Iteos Therapeutics Inc., discusses what his company brings GSK in a massive new deal. Hosted on Acast. See acast.com/privacy for more information.

Finally, a new medicine for Alzheimer's disease 10.06.2021 9:17

Biogen's vice president of global and U.S. medical affairs for Alzheimer's disease offers insight into Aduhelm. Hosted on Acast. See acast.com/privacy for more information.

The BioWorld Insider Podcast - trailer 04.06.2021 0:35

Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma's dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. The BioWorld Insider podcast lets you hear directly from the movers and shakers whose collective work is chan...